Fibrinogen isoforms as potential blood-based biomarkers of Alzheimer's disease using a proteomics approach
Objective: Alzheimer's disease (AD), the commonest form of dementia which is characterized by progressive decline in cognitive function, can only be definitively diagnosed after death. Although biomarkers may aid diagnosis, currently available AD biomarkers, which are predominantly based on cer...
Saved in:
Main Authors: | Rehiman, Siti Hajar, Lim, Siong Meng, Lim, Fei Tieng, Chin, Ai-Vyrn, Tan, Maw Pin, Kamaruzzaman, Shahrul Bahyah, Ramasamy, Kalavathy, Abdul Majeed, Abu Bakar |
---|---|
Format: | Article |
Published: |
Taylor & Francis Ltd
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/41517/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarkers in neurology
Published: (2020) -
Role of melatonin in Alzheimer's disease: From preclinical studies to novel melatonin-based therapies
by: Roy, Jaydeep, et al.
Published: (2022) -
Editorial: biomarkers in neurology
by: Mondello, Stefania, et al.
Published: (2020) -
Pharmacotherapy of alzheimer’s disease: seeking clarity in a time of uncertainty
by: Ibrahim, Nurul Husna, et al.
Published: (2020) -
Proteomic profiling in Schizophrenia: a brief review
by: Abd. Rahim, Nour El Huda, et al.
Published: (2021)